Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Telbivudine Therapy in HBeAg-positive Pregnant Women to Prevent Mother-to-infant Transmission of HBV

This study has been completed.
Sponsor:
Collaborators:
Taixing People's Hospital
Fourth People's Hospital of Zhenjiang, China
Wuxi Maternal and Child Health Hospital
Kunshan First People Hospital
Information provided by (Responsible Party):
Yi-Hua Zhou, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
ClinicalTrials.gov Identifier:
NCT01637844
First received: July 4, 2012
Last updated: November 30, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2014
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)